Back
Outlook Therapeutics Quote, Financials, Valuation and Earnings
Sell
29
OTLK
Outlook Therapeutics
Last Price:
7.45
Seasonality Move:
22.9%
7 Day Trial
ALL ACCESS PASS
$
7
Outlook Therapeutics Price Quote
$7.45
+0.02 (+0.68%)
(Updated: May 16, 2024 at 6:16 AM ET)
Outlook Therapeutics Key Stats
Sell
29
Outlook Therapeutics (OTLK)
is a Sell
Day range:
$7.35 - $7.57
52-week range:
$4.00 - $40.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.79
P/B ratio:
0%
Volume:
225.2K
Avg. volume:
279.5K
1-year change:
-69.04%
Market cap:
$160.4M
Revenue:
$0
EPS:
$-4
How Much Does Outlook Therapeutics Make?
Data Unavailable
Is Outlook Therapeutics Growing As A Company?
Data Unavailable
Outlook Therapeutics Stock Price Performance
-
Did Outlook Therapeutics Stock Go Up Last Month?
Outlook Therapeutics share price went down by -13.81% last month -
Did OTLK's Share Price Rise Over The Last Year?
OTLK share price fell by -69.04% over the past 1 year
What Is Outlook Therapeutics 52-Week High & Low?
-
What Is Outlook Therapeutics’s 52-Week High Share Price?
Outlook Therapeutics has traded as high as $40.60 over the past 52 weeks -
What Is Outlook Therapeutics’s 52-Week Low Share Price?
Outlook Therapeutics has traded as low as $4.00 over the past 52 weeks
Outlook Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Outlook Therapeutics?
-
How Much Debt Does Outlook Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Outlook Therapeutics Have?
Cash and short term investments quarterly total is $10.4M -
What Is Outlook Therapeutics’s Book Value Per Share?
Book value per share is -1.87
Is Outlook Therapeutics Cash Flow Positive?
-
What Is OTLK Cash Flow From Operations?
Cash flow from operations (TTM) is -$47.1M -
What Is Outlook Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.1M -
What Is Outlook Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Outlook Therapeutics Return On Invested Capital
Data Unavailable
Outlook Therapeutics Earnings Date & Stock Price
-
What Is Outlook Therapeutics's Stock Price Today?
A single share of OTLK can be purchased today for 7.43 -
What Is Outlook Therapeutics’s Stock Symbol?
Outlook Therapeutics trades on the nasdaq under the ticker symbol: OTLK -
When Is Outlook Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Outlook Therapeutics is scheduled on May 16, 2024 -
When Is OTLK's next ex-dividend date?
Outlook Therapeutics's next ex-dividend date is May 15, 2020 -
How To Buy Outlook Therapeutics Stock?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Outlook Therapeutics Competitors
-
Who Are Outlook Therapeutics's Competitors?
Below is a list of companies who compete with Outlook Therapeutics or are related in some way:
Outlook Therapeutics Dividend Yield
Data Unavailable
Outlook Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 27.06% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 39.86 |
| Upside from Last Price: | 436.44% |